Skip to main content
. 2022 Apr 18;24(7):1267–1276. doi: 10.1111/dom.14695

TABLE 1.

Clinical and metabolic characteristics of study participants stratified by dietary‐induced changes in postload insulin clearance at enrolment and after the 12‐week intervention

Marked increase (n = 10) Minor change (n = 7) P
Week 0 Week 12 Week 0 Week 12 Group Time Interaction
Age (y) 14.90 [6.60] 12.40 [3.40] Ns
Sex (n, %)
Boys 4, 40.0% 2, 28.6% Ns
Girls 6, 60.0% 5, 71.4%
Race or ethnicity (n, %)
Caucasian 3, 30.0% 4, 57.1% Ns
African American 2, 20.0% 0, 0.0 %
Hispanic 5, 50.0% 3, 42.9%
Body weight (kg) 88.4 ± 23.5 87.4 ± 24.1 94.5 ± 34.7 94.6 ± 34.4 Ns Ns Ns
Body mass index (kg/m2) 34.0 ± 7.3 33.4 ± 7.9 35.4 ± 8.5 35.2 ± 8.7 Ns Ns Ns
Body composition
Fat mass (%) 37.28 ± 14.67 41.26 ± 19.28 42.18 ± 17.97 39.10 ± 13.77 Ns Ns Ns
Waist circumference (cm) 113.2 ± 13.0 107.6 ± 17.2 113.4 ± 19.9 116.8 ± 16.0 Ns Ns Ns
Waist‐to‐hip ratio (ratio) 0.96 [0.07] 0.98 [0.07] 1.00 [0.12] 1.00 [0.04] Ns Ns Ns
HFF% (%) 15.45 [19.10] 10.85 [20.80] 12.50 [5.90] 8.00 [10.50] Ns .001 Ns
VAT (cm2) 83.9 ± 40.9 71.9 ± 37.3 79.2 ± 30.8 79.0 ± 33.2 Ns Ns Ns
SAT (cm2) 495.2 [303.2] 496.1 [167.5] 590.9 [435.6] 669.1 [382.3] Ns Ns Ns
Alanine aminotransferase (U/L) 28 [27] 13 [19] 46 [43] 22 [38] Ns .007 .089
Lipid profile
Total cholesterol (mg/dl) 152.8 ± 17.6 143.9 ± 15.7 169.6 ± 29.8 153.4 ± 25.5 Ns .067 Ns
HDL cholesterol (mg/dl) 38.6 ± 4.7 38.8 ± 6.6 43.3 ± 10.7 39.1 ± 10.1 Ns .001 .029
LDL cholesterol (mg/dl) 83.6 ± 10.3 80.8 ± 13.2 94.9 ± 26.0 86.4 ± 15.8 Ns Ns Ns
Triglycerides (mg/dl) 133 [133] 100 [90] 130 [208] 111 [58] Ns Ns Ns

Note: Continuous variables are reported as median [interquartile range] or mean ± SD. Categorical variables are reported as count (%). Group differences were analysed by two‐way ANOVA for repeated measures including group, time, and group × time interaction as factors. P values less than .10 are reported.

Abbreviations: HDL, high‐density lipoprotein; HFF%, hepatic fat fraction; LDL, low‐density lipoprotein; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue.